跳至主要内容
临床试验/EUCTR2011-004311-23-GB
EUCTR2011-004311-23-GB进行中(未招募)1 期

A randomised, placebo controlled trial to study the effect of heme-arginate on heme-oxygenase-1 induction and renal function in recipients of deceased donor renal transplants. - Heme-oxygenase-1 in renal transplantation (HOT study)v.1

niversity of Edinburgh0 个研究点目标入组 40 人开始时间: 2011年11月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • All patients receiving a single kidney deceased donor transplant.
  • All patients receiving standard immunosuppression.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • Patients unable to receive the standard immunosuppressive regimen
  • Patients unable to give informed consent
  • Patients with known hypersensitivity reactions to HA
  • Patients receiving more than one organ
  • Patients receiving their 3rd or subsequent kidney transplant
  • Patients who are fully anticoagulated pre-operatively
  • Patients on combined anti-platelet agents

研究者

发起方
niversity of Edinburgh

相似试验